nodes	percent_of_prediction	percent_of_DWPC	metapath
Triflupromazine—Desipramine—SLC22A4—Crohn's disease	0.0223	0.248	CrCbGaD
Triflupromazine—Imipramine—SLC22A4—Crohn's disease	0.0189	0.21	CrCbGaD
Triflupromazine—Desipramine—SLC22A5—Crohn's disease	0.0168	0.186	CrCbGaD
Triflupromazine—Acepromazine—ALB—Crohn's disease	0.00761	0.0844	CrCbGaD
Triflupromazine—Thioproperazine—ALB—Crohn's disease	0.00744	0.0825	CrCbGaD
Triflupromazine—Pipotiazine—ALB—Crohn's disease	0.00732	0.0812	CrCbGaD
Triflupromazine—Clomipramine—ALB—Crohn's disease	0.00579	0.0642	CrCbGaD
Triflupromazine—Chlorpromazine—ALB—Crohn's disease	0.00397	0.044	CrCbGaD
Triflupromazine—CHRM1—GPCR ligand binding—PTGER4—Crohn's disease	0.00171	0.00188	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—CCR9—Crohn's disease	0.0017	0.00187	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR ligand binding—PTGER4—Crohn's disease	0.00169	0.00186	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—TAGAP—Crohn's disease	0.00169	0.00185	CbGpPWpGaD
Triflupromazine—ABCB1—Allograft Rejection—IFNG—Crohn's disease	0.00169	0.00185	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—CCR9—Crohn's disease	0.00166	0.00183	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—CCR9—Crohn's disease	0.00164	0.0018	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.00161	0.00177	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.00161	0.00177	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—TAGAP—Crohn's disease	0.00159	0.00175	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—CCR6—Crohn's disease	0.00158	0.00174	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—GPR65—Crohn's disease	0.00158	0.00173	CbGpPWpGaD
Triflupromazine—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	0.00157	0.00172	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—MTMR3—Crohn's disease	0.00155	0.0017	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—GPR65—Crohn's disease	0.00154	0.0017	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—CCR9—Crohn's disease	0.00154	0.00169	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—GPR65—Crohn's disease	0.00152	0.00168	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—CCR9—Crohn's disease	0.00151	0.00166	CbGpPWpGaD
Triflupromazine—ABCB1—Allograft Rejection—IL1B—Crohn's disease	0.0015	0.00165	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—CCR6—Crohn's disease	0.00149	0.00164	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—CCR9—Crohn's disease	0.00149	0.00164	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—RSPO3—Crohn's disease	0.00147	0.00162	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—CCR6—Crohn's disease	0.00143	0.00158	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—GPR65—Crohn's disease	0.00143	0.00157	CbGpPWpGaD
Triflupromazine—CHRM2—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	0.00142	0.00156	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—GPR65—Crohn's disease	0.0014	0.00154	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—SEL1L—Crohn's disease	0.0014	0.00154	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—RSPO3—Crohn's disease	0.00139	0.00153	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—PTGER4—Crohn's disease	0.00139	0.00153	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—ACKR2—Crohn's disease	0.00139	0.00152	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—GPR65—Crohn's disease	0.00138	0.00152	CbGpPWpGaD
Triflupromazine—CHRM2—SIDS Susceptibility Pathways—IL1B—Crohn's disease	0.00136	0.0015	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—ACKR2—Crohn's disease	0.00136	0.00149	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—CCR6—Crohn's disease	0.00135	0.00149	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—ACKR2—Crohn's disease	0.00134	0.00147	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—SEL1L—Crohn's disease	0.00132	0.00145	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MLN—Crohn's disease	0.00131	0.00144	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—PTGER4—Crohn's disease	0.00131	0.00144	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MLN—Crohn's disease	0.00129	0.00141	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CCR9—Crohn's disease	0.00128	0.00141	CbGpPWpGaD
Triflupromazine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.00128	0.0014	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MLN—Crohn's disease	0.00127	0.00139	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—PTGER4—Crohn's disease	0.00126	0.00139	CbGpPWpGaD
Triflupromazine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.00122	0.00134	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—FADS1—Crohn's disease	0.00121	0.00133	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CCR9—Crohn's disease	0.00121	0.00133	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—TAGAP—Crohn's disease	0.0012	0.00132	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—PTGER4—Crohn's disease	0.00119	0.00131	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—GPR65—Crohn's disease	0.00119	0.00131	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—IL3—Crohn's disease	0.00118	0.0013	CbGpPWpGaD
Triflupromazine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00118	0.0013	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—TAGAP—Crohn's disease	0.00118	0.00129	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—TAGAP—Crohn's disease	0.00116	0.00128	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00115	0.00126	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.00114	0.00125	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—GPX4—Crohn's disease	0.00113	0.00124	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—CCR6—Crohn's disease	0.00112	0.00124	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—GPR65—Crohn's disease	0.00112	0.00123	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—IL3—Crohn's disease	0.00112	0.00123	CbGpPWpGaD
Triflupromazine—DRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00112	0.00123	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—CCR6—Crohn's disease	0.0011	0.00121	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—GCKR—Crohn's disease	0.00109	0.0012	CbGpPWpGaD
Triflupromazine—ABCB1—Allograft Rejection—TNF—Crohn's disease	0.00109	0.0012	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—CCR6—Crohn's disease	0.00109	0.00119	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00108	0.00119	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—IL3—Crohn's disease	0.00108	0.00118	CbGpPWpGaD
Triflupromazine—DRD2—G alpha (i) signalling events—CXCL8—Crohn's disease	0.00106	0.00116	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—RSPO3—Crohn's disease	0.00105	0.00115	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—RASGRP1—Crohn's disease	0.00104	0.00114	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—RSPO3—Crohn's disease	0.00103	0.00113	CbGpPWpGaD
Triflupromazine—CHRM2—G alpha (i) signalling events—CXCL8—Crohn's disease	0.00102	0.00112	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—CCR6—Crohn's disease	0.00102	0.00112	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—RSPO3—Crohn's disease	0.00101	0.00112	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—IL3—Crohn's disease	0.00101	0.00111	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.00101	0.00111	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—CCR6—Crohn's disease	0.000999	0.0011	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—SEL1L—Crohn's disease	0.000995	0.00109	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—PTGER4—Crohn's disease	0.00099	0.00109	CbGpPWpGaD
Triflupromazine—CHRM2—SIDS Susceptibility Pathways—TNF—Crohn's disease	0.000988	0.00109	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—CCR6—Crohn's disease	0.000986	0.00108	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000981	0.00108	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—SEL1L—Crohn's disease	0.000974	0.00107	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000969	0.00106	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—SEL1L—Crohn's disease	0.000962	0.00106	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—PTGER4—Crohn's disease	0.000956	0.00105	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CCR9—Crohn's disease	0.00091	0.001	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR ligand binding—CXCL8—Crohn's disease	0.0009	0.00099	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—PTGER4—Crohn's disease	0.000899	0.000988	CbGpPWpGaD
Triflupromazine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000897	0.000986	CbGpPWpGaD
Triflupromazine—DRD1—Circadian rythm related genes—IL6—Crohn's disease	0.000893	0.000981	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CCR9—Crohn's disease	0.000891	0.000979	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PLA2G4F—Crohn's disease	0.000889	0.000977	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—PTGER4—Crohn's disease	0.00088	0.000967	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CCR9—Crohn's disease	0.00088	0.000967	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—PTGER4—Crohn's disease	0.000868	0.000954	CbGpPWpGaD
Triflupromazine—DRD1—GPCR ligand binding—CXCL8—Crohn's disease	0.000849	0.000933	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CCR6—Crohn's disease	0.000847	0.000931	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—GPR65—Crohn's disease	0.000846	0.00093	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—IL3—Crohn's disease	0.000843	0.000927	CbGpPWpGaD
Triflupromazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000842	0.000925	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—IL2RA—Crohn's disease	0.000829	0.000912	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—GPR65—Crohn's disease	0.000828	0.00091	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—IL3—Crohn's disease	0.000825	0.000907	CbGpPWpGaD
Triflupromazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000824	0.000906	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—GPR65—Crohn's disease	0.000818	0.000899	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000815	0.000896	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—IL3—Crohn's disease	0.000814	0.000895	CbGpPWpGaD
Triflupromazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000813	0.000894	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CCR6—Crohn's disease	0.000799	0.000878	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000798	0.000877	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	0.000798	0.000877	CbGpPWpGaD
Triflupromazine—CHRM2—SIDS Susceptibility Pathways—IL6—Crohn's disease	0.000797	0.000877	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000788	0.000866	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000782	0.00086	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	0.00078	0.000858	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—RBX1—Crohn's disease	0.000766	0.000842	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—IL3—Crohn's disease	0.000766	0.000841	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—MTMR3—Crohn's disease	0.000756	0.000831	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—IL2RA—Crohn's disease	0.000753	0.000828	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—IL3—Crohn's disease	0.000749	0.000824	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PTGER4—Crohn's disease	0.000746	0.00082	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—RASGRP1—Crohn's disease	0.00074	0.000814	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—IL3—Crohn's disease	0.00074	0.000813	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000725	0.000797	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—RBX1—Crohn's disease	0.000722	0.000794	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—RASGRP1—Crohn's disease	0.000715	0.000786	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—IL2RA—Crohn's disease	0.00071	0.000781	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PTGER4—Crohn's disease	0.000703	0.000773	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	0.000683	0.00075	CbGpPWpGaD
Triflupromazine—DRD2—Circadian rythm related genes—IL6—Crohn's disease	0.000674	0.000741	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—UBE2D1—Crohn's disease	0.000672	0.000738	CbGpPWpGaD
Triflupromazine—CHRM1—Circadian rythm related genes—IL6—Crohn's disease	0.00066	0.000725	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—RIPK2—Crohn's disease	0.000651	0.000716	CbGpPWpGaD
Triflupromazine—DRD2—GPCR ligand binding—CXCL8—Crohn's disease	0.000641	0.000705	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—IL3—Crohn's disease	0.000635	0.000698	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—UBE2D1—Crohn's disease	0.000633	0.000696	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR ligand binding—CXCL8—Crohn's disease	0.000627	0.00069	CbGpPWpGaD
Triflupromazine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000625	0.000687	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR ligand binding—CXCL8—Crohn's disease	0.000619	0.000681	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—RASGRP1—Crohn's disease	0.000614	0.000675	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—RIPK2—Crohn's disease	0.000614	0.000675	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CCR6—Crohn's disease	0.000603	0.000663	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IL3—Crohn's disease	0.000599	0.000658	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—IL2RA—Crohn's disease	0.000591	0.000649	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CCR6—Crohn's disease	0.00059	0.000649	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—FADS1—Crohn's disease	0.000589	0.000648	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CCR6—Crohn's disease	0.000583	0.00064	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—RASGRP1—Crohn's disease	0.000579	0.000637	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000578	0.000635	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism of proteins—CXCL8—Crohn's disease	0.000572	0.000629	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—IL2RA—Crohn's disease	0.000571	0.000627	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—JAK2—Crohn's disease	0.000558	0.000613	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—SOCS1—Crohn's disease	0.000557	0.000612	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GPX4—Crohn's disease	0.000552	0.000606	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—RBX1—Crohn's disease	0.000545	0.000599	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	0.000539	0.000592	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—IL2RA—Crohn's disease	0.000536	0.000589	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—RBX1—Crohn's disease	0.000534	0.000587	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GCKR—Crohn's disease	0.000533	0.000586	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PTGER4—Crohn's disease	0.000531	0.000584	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—TYK2—Crohn's disease	0.000531	0.000583	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—RBX1—Crohn's disease	0.000527	0.000579	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—JAK2—Crohn's disease	0.000526	0.000578	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—SOCS1—Crohn's disease	0.000525	0.000577	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—IL2RA—Crohn's disease	0.000525	0.000577	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PTGER4—Crohn's disease	0.00052	0.000571	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—IL2RA—Crohn's disease	0.000518	0.000569	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PTGER4—Crohn's disease	0.000513	0.000564	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—CXCL8—Crohn's disease	0.000509	0.000559	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—JAK2—Crohn's disease	0.000506	0.000556	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—TYK2—Crohn's disease	0.0005	0.00055	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—SMAD3—Crohn's disease	0.000481	0.000528	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—CXCL8—Crohn's disease	0.00048	0.000527	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—UBE2D1—Crohn's disease	0.000478	0.000526	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—JAK2—Crohn's disease	0.000477	0.000525	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—UBE2D1—Crohn's disease	0.000468	0.000514	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—RIPK2—Crohn's disease	0.000464	0.00051	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—CXCL8—Crohn's disease	0.000462	0.000508	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—UBE2D1—Crohn's disease	0.000462	0.000508	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—RIPK2—Crohn's disease	0.000454	0.000499	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—SMAD3—Crohn's disease	0.000453	0.000498	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IL3—Crohn's disease	0.000452	0.000497	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—RIPK2—Crohn's disease	0.000448	0.000492	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—IL2RA—Crohn's disease	0.000445	0.000489	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IL3—Crohn's disease	0.000443	0.000486	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—RASGRP1—Crohn's disease	0.000437	0.000481	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IL3—Crohn's disease	0.000437	0.00048	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—CXCL8—Crohn's disease	0.000436	0.000479	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—RASGRP1—Crohn's disease	0.000428	0.000471	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—RASGRP1—Crohn's disease	0.000423	0.000464	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IL2RA—Crohn's disease	0.00042	0.000461	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—JAK2—Crohn's disease	0.000397	0.000436	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—SOCS1—Crohn's disease	0.000396	0.000436	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—JAK2—Crohn's disease	0.000388	0.000427	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—SOCS1—Crohn's disease	0.000388	0.000426	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—JAK2—Crohn's disease	0.000383	0.000421	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—SOCS1—Crohn's disease	0.000383	0.000421	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—TYK2—Crohn's disease	0.000378	0.000415	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—TYK2—Crohn's disease	0.00037	0.000406	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—TYK2—Crohn's disease	0.000365	0.000401	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—CXCL8—Crohn's disease	0.000362	0.000398	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000362	0.000398	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—JAK2—Crohn's disease	0.00036	0.000396	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000355	0.00039	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—JAK2—Crohn's disease	0.000353	0.000388	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—CXCL8—Crohn's disease	0.00035	0.000385	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—JAK2—Crohn's disease	0.000348	0.000383	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—ALB—Crohn's disease	0.000348	0.000382	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—SMAD3—Crohn's disease	0.000342	0.000376	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—SMAD3—Crohn's disease	0.000335	0.000368	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—SMAD3—Crohn's disease	0.000331	0.000363	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—CXCL8—Crohn's disease	0.000329	0.000362	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—CXCL8—Crohn's disease	0.000322	0.000354	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—CXCL8—Crohn's disease	0.000318	0.000349	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IL2RA—Crohn's disease	0.000317	0.000348	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—TYK2—Crohn's disease	0.000313	0.000345	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IL2RA—Crohn's disease	0.00031	0.000341	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IL2RA—Crohn's disease	0.000306	0.000336	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PTGS2—Crohn's disease	0.000304	0.000334	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—JAK2—Crohn's disease	0.000299	0.000329	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—TYK2—Crohn's disease	0.000296	0.000325	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—JAK2—Crohn's disease	0.000282	0.00031	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CXCL8—Crohn's disease	0.000273	0.0003	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—IL6—Crohn's disease	0.00026	0.000285	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CXCL8—Crohn's disease	0.000257	0.000283	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—IL6—Crohn's disease	0.000245	0.000269	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—TYK2—Crohn's disease	0.000223	0.000245	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—STAT3—Crohn's disease	0.00022	0.000241	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—TYK2—Crohn's disease	0.000218	0.00024	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—TYK2—Crohn's disease	0.000216	0.000237	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—JAK2—Crohn's disease	0.000213	0.000234	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—JAK2—Crohn's disease	0.000208	0.000229	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—STAT3—Crohn's disease	0.000207	0.000228	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—JAK2—Crohn's disease	0.000206	0.000226	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CXCL8—Crohn's disease	0.000194	0.000214	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CXCL8—Crohn's disease	0.00019	0.000209	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CXCL8—Crohn's disease	0.000188	0.000206	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—IL6—Crohn's disease	0.000185	0.000203	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—IL6—Crohn's disease	0.000181	0.000199	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—IL6—Crohn's disease	0.000179	0.000196	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—ALB—Crohn's disease	0.00017	0.000186	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—STAT3—Crohn's disease	0.000156	0.000172	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—IL6—Crohn's disease	0.000153	0.000169	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—STAT3—Crohn's disease	0.000153	0.000168	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—STAT3—Crohn's disease	0.000151	0.000166	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PTGS2—Crohn's disease	0.000148	0.000163	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IL6—Crohn's disease	0.000145	0.000159	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IL6—Crohn's disease	0.000109	0.00012	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IL6—Crohn's disease	0.000107	0.000117	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IL6—Crohn's disease	0.000105	0.000116	CbGpPWpGaD
